Ultraviolet radiation and malignant melanoma

Clinics in Dermatology

Volumn 16, Issue 1, 1998, Pages 67-73

  Tsao, Hensin ^a   Sober, Arthur J ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OZONE; PSORALEN; SUNSCREEN;

DISEASE MODEL; ENVIRONMENTAL EXPOSURE; MELANOMA; MIGRATION; PRIORITY JOURNAL; PUVA; RADIATION CARCINOGENESIS; RADIATION EXPOSURE; REVIEW; SOLAR RADIATION; SUNBURN; SUNLIGHT; TUMOR SUPPRESSOR GENE; ULTRAVIOLET B RADIATION; ULTRAVIOLET RADIATION; XERODERMA PIGMENTOSUM;

EID: 0031868216     PISSN: 0738081X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0738-081X(97)00191-0     Document Type: Article

References (78)

1. 1. Parker SL, Tony T, Bolden S, et al. Cancer statistics, 1997. CA Cancer J Clin 1997;47:5-27.
2. 2. Armstrong BK, Kricker A. Skin cancer. Dermatol Clin 1995;13:583-94.
3. 3. Longstreth JD, Lea CS, Kripke ML. Ultraviolet radiation and other putative causes of melanoma. In: Balch CM, Houghton AN, Milton GW, et al, editors. Cutaneous melanoma. Philadelphia: JB Lippincott, 1992;2:46-58.
4. 4. Cole CA, Forbes D, Davies RE. An action spectrum for UV photocarcinogenesis. Photochem Photobiol 1986;43:275-84.
5. 5. Langley RGB, Sober AJ. A clinical review of the evidence for the role of ultraviolet radiation in the etiology of cutaneous melanoma. Cancer Invest 1997;15:561-7.
6. 6. Brash DE. UV mutagenic photoproducts in Escherichia coli and human cells: A molecular genetics perspective on human skin cancer. Photochem Photobiol 1988;48:59-66.
7. 7. Raybaud F, Noguchi T, Marcis I, et al. Detection of a low frequency of activated ras genes in human melanomas using a tumorigenicity assay. Cancer Res 1988;48:950-3.
8. 8. Herlyn M, Satyamoorthy K. Activated ras, yet another player in melanoma? Am J Pathol 1996;149:739-44.
9. 9. Brash DE, Rudolph JA, Simon JA, et al. A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proc Natl Acad Sci USA 1991;88:10124-8.
10. 10. Castresana JS, Rubio MP, Vazquez JJ, et al. Lack of allelic deletion and point mutation as mechanisms of p53 activation in human malignant melanoma. Int J Cancer 1993; 55:562-5.
11. 11. Pedley J, Ablett EM, Pettit A, et al. Inhibition of retinoblastoma protein translation by UVB in human melanocytic cells and reduced cell cycle arrest following repeated irradiation. Oncogene 1996;13:1335-42.
12. 12. Sherr CJ. Cancer cell cycles. Science 1996;274:1672-7.
13. 13. Ley RD. Photoreactivation of UV-induced pyrimidine dimers and erythema in the marsupial Monodelphis domestica. Proc Natl Acad Sci USA, 1985;82:2409-11.
14. 14. Ley RD, Applegate LA, Padilla RS, et al. Ultraviolet radiation-induced malignant melanoma in Monodelphis domestica. Photochem Photobiol 1989;50:1-5.
15. 15. Setlow RB, Woodhead AD, Grist E. Animal model for ultraviolet radiation-induced melanoma: Platyfish-swordtail hybrid. Proc Natl Acad Sci USA 1989;86:8922-6.
16. 16. Friend SH. Genetic models for studying cancer susceptibility. Science 1993;259:774-5.
17. 17. Soballe PW, Montone KT, Satyamoorthy K, et al. Carcinogenesis in human skin grafted to SCID mice. Cancer Res 1996;56:757-64.
18. 18. Herlyn M. The basic biology of melanoma. Melanoma Res 1997;7:S3.
19. 19. Toews GB, Bergstresser PR, Streilein JW. Epidermal Langerhans cell density determines whether contact hypersensitivity or unresponsiveness follows skin painting with DNFB. J Immunol 1980;124:445-53.
20. 20. Romerdahl CA, Donawho C, Fidler IJ, et al. Effect of ultraviolet-B radiation on the in vivo growth of murine melanoma cells. Cancer Res 1988;48:4007-10.
21. 21. Romerdahl CA, Stephens LC, Bucana C, et al. The role of ultraviolet radiation in the induction of melanocytic skin tumors in inbred mice. Cancer Commun 1989;1:209-16.
22. 22. Masahito P, Ishikawa T, Sugano H. Pigment cells and pigment cell tumors in fish. J Invest Dermatol 1989;92: 266S-270S.
23. 23. Bradl M, Klein-Szanto A, Porter S, et al. Malignant melanoma in transgenic mice. Proc Natl Acad Sci USA 1991; 88:164-8.
24. 24. Larue L, Dougherty N, Bradl M, et al. Melanocyte culture lines from Tyr-SV40E transgenic mice: Models for the molecular genetic evolution of malignant melanoma. Oncogene 1993;8:523-31.
25. 25. Hussussian CJ, Struewing JP, Goldstein AM, et al. Germline p16 mutations in familial melanoma. Nature Genet 1994;8:15-21.
26. 26. Flores JF, Walker GJ, Glendening JM, et al. Loss of the p16INK4a and p15INK4b genes, as well as neighboring 9p21 markers in sporadic melanoma. Cancer Res 1996;56: 5023-32.
27. 27. Serrano M, Lee H, Chin L, et al. Role of the INK4a locus in tumor suppression and cell mortality. Cell 1996;85:27-37.
28. 28. Elwood JM. Melanoma and sun exposure. Semin Oncol 1996;23:650-66.
29. 29. Lancaster HO, Nelson J. Sunlight as a cause of melanoma: A clinical survey. Med J Australia 1957;1:452-6.
30. 30. Builliard JL, Cox B, Elwood JM. Latitude gradients in melanoma incidence and mortality in the non-Maori population of New Zealand. Cancer Causes Control 1994;5: 234-40.
31. 31. Magnus K. Incidence of malignant melanoma of the skin in Norway 1955-1970. Cancer 1973;32:1275-86.
32. 32. Scotto J, Fears TR, Fraumeni J. Solar radiation. In: Schottenfeld D, Fraumeni JF, editors. Cancer epidemiology and prevention. Philadelphia: WB Saunders, 1982:254-76.
33. 33. Grin-Jorgensen CM, Rigel DS, Friedman RJ. The worldwide incidence of malignant melanoma. In: Balch CM, Houghton AN, Milton GW, et al., editors. Cutaneous melanoma. Philadelphia: JP Lippincott 1992;2:27-39.
34. 34. Autier P, Dore J, Legeune F, et al. Recreational exposure to sunlight and lack of information as risk factors for cutaneous malignant melanoma. Results of an European Organization for Research and Treatment of Cancer (EORTC) case control study in Belgium, France and Germany. Melanoma Res 1994;4:79-85.
35. 35. Cooke KR, Skegg DCG, Fraser J. Socioeconomic status, indoor and outdoor work, and malignant melanoma. Int J Cancer 1984;34:57-62.
36. 36. Bell M, Beyl CM, Schopf RE, et al. Light exposure of the lower leg as a pathogenetic factor in the occurrence of malignant melanoma. Dermatology 1992;185:257-61.
37. 37. Holman CDJ, Armstrong BK, Heenan PJ. Relationship of cutaneous malignant melanoma to individual sunlight-exposure habits. J Natl Cancer Inst 1986;76:403-14.
38. 38. Khlat M, Vail A, Parkin M, et al. Mortality from melanoma in migrants to Australia: Variation by age at arrival and duration of stay. Am J Epidemiol 1992;135:1103-13.
39. 39. Mack TM, Floderus B. Malignant melanoma risk by nativity, place of residence at diagnosis, and age at migration. Cancer Causes Control 1991;2:401-11.
40. 40. Holman CDJ, Armstrong BK. Cutaneous malignant melanoma and indicators of total accumulated exposure to the sun: An analysis separating histogenic types. J Natl Cancer Inst 1984;73:75-82.
41. 41. Weinstock MA, Colditz GA, Willet WC, et al. Nonfamilial cutaneous melanoma incidence in women associated with sun exposure before 20 years of age. Pediatrics 1989;84: 199-204.
42. 42. Westerdahl J, Olsson H, Ingavar C, et al. Southern travelling habits with special reference to tumour site in Swedish melanoma patients. Anticancer Res 1992;12:1539-42.
43. 43. Walter SD, Marrett LD, From L, et al. The association of cutaneous malignant melanoma with the use of sunbeds and sunlamps. Am J Epidemiol 1990;131:232-43.
44. 44. Holly EA, Aston DA, Cress RD, et al. Exposure to sunlight, ability to tan and other risk factors relative to UV light. Am J Epidemiol 1995;141:923-41.
45. 45. Setlow RB, Grist E, Thompson K, et al. Wavelengths effective in induction of malignant melanoma. Proc Natl Acad Sci USA 1993;90:6666-70.
46. 46. Stern RS, Naird N, Melski J, et al. Cutaneous squamous cell carcinoma in patients treated with PUVA. N Engl J Med 1984;310:1156-61.
47. 47. Musajo L, Rodighiero G. Studies of the photo C4-cycloaddition reactions between skin-photosensitizing furocoumarins and nucleic acids. Photochem Photobiol 1970;11:27-35.
48. 48. Swanbeck G, Thyresson M. Induction of respiration-deficient mutation in yeasts by psoralen and light. J Invest Dermatol 1974;63:242-4.
49. 49. Dunnick JK, Forbes PD, Eustis SL, et al. Tumors of the skin in the HRA/Skh mouse after treatment with 8-methoxypsoralen and UVA radiation. Fund Appl Toxicol 1991;16:92-102.
50. 50. Garland CF, Garland FC, Gorham ED. Rising trends in melanoma. A hypothesis concerning sunscreen effectiveness. Ann Epidemiol 1993;3:103-10.
51. 51. Lowe NJ, Breedings, J. Evaluation of sunscreen protection by measurement of epidermal DNA synthesis. J Invest Dermatol 1980;74:181-2.
52. 52. Freeman SE, Ley RD, Ley KD. Sunscreen protection against UV-induced pyrimidine dimers in DNA of human skin in situ. Photodermatology 1988;5:243-7.
53. 53. Ananthaswamy HN, Loughlin SM, Cox P, et al. Sunlight and skin cancer: Inhibition of p53 mutations in UV-irradiated mouse skin by sunscreens. Nature Med 1997;3:510-4.
54. 54. Thompson SC, Jolley D, Marks R. Reduction of solar keratoses by regular sunscreen. New Engl J Med 1993;329: 1147-51.
55. 55. Autier P, Dore JF, Schifflers E, et al. Melanoma and the use of sunscreens: An EORTC case-control study in Germany, Belgium and France. Int J Cancer 1995;61:749-55.
56. 56. Westerdahl J, Olsson H, Masback A, et al. Is the use of sunscreens a risk factor for malignant melanoma? Melanoma Res 1995;5:59-65.
57. 57. Kochevar I, Pathak M, Parrish JA. Photophysics, photochemistry, and photobiology. In: Fitzpatrick TB, Eisen AZ, Wolff K, et al., editors. Dermatology in general medicine. New York: McGraw Hill, 1993;4:1627.
58. 58. Kerr JB, McElroy CT. Evidence for large upward trends of ultraviolet B radiation linked to ozone depletion. Science 1993;262:1032-4.
59. 59. Elwood JM. Epidemiology of melanoma: Its relationship to ultraviolet radiation and ozone depletion. In: Russel-Jones R, Wigley W, editors. Ozone depletion: Health and environmental consequences. Chichester: Wiley, 1989;169-89.
60. 60. Russel-Jones R. Ozone depletion and cancer risk. Lancet 1987;ii:443-6.
61. 61. Kraemer KH. Heritable diseases with increased sensitivity to cellular injury. In: Fitzpatrick TB, Eisen AZ, Wolff K, et al, editors. Dermatology in general medicine. New York: McGraw Hill, 1993;4:1794-991.
62. 62. Kraemer KH, Lee MM, Andrews AD, et al. The role of sunlight and DNA repair in melanoma and nonmelanoma skin cancer. Arch Dermatol 1994;130:1018-21.
63. 62. Nelemans PJ, Rampen FHJ, Groenendal H, et al. Swimming and the risk of cutaneous melanoma. Melanoma Res 1994;4:281-6.
64. 63. Zanetti R, Franceschi S, Rosso S, et al. Cutaneous melanoma and sunburns in childhood in a southern European population. Eur J Cancer 1992;28A:1172-6.
65. 64. Dubin N, Pasternack BS, Moseson M. Simultaneous assessment of risk factors for malignant melanoma and non-melanoma skin lesions, with emphasis on sun exposure and related variables. Int J Epidemiol 1990;19:811-9.
66. 65. Zaridze D, Mukeria A, Duffy SW. Risk factors for skin melanoma in Moscow. Int J Cancer 1992;52:159-61.
67. 66. Westerdahl J, Olsson H, Ingvar C. At what age do sunburn episodes play a crucial role for the development of malignant melanoma? Eur J Cancer 1994;30A:1647-54.
68. 67. MacKie RM, Aitchison T. Severe sunburn and subsequent risk of primary cutaneous malignant melanoma in Scotland. Br J Cancer 1982;46:955-60.
69. 68. Lew RA, Sober AJ, Cook N, et al. Sun exposure habits in patients with cutaneous melanoma: A case control study. J Dermatol Surg Oncol 1983;9:981-6.
70. 69. Elwood JM, Gallagher RP, Davison J, et al. Sunburn, suntan and the risk of cutaneous malignant melanoma -The Western Canada Melanoma Study. Br J Cancer 1985; 51:543-9.
71. 70. Green A, Siskind V, Bain C, et al. Sunburn and malignant melanoma. Br J Cancer 1985;51:393-7.
72. 71. Sorahan T, Grimley RP. The aetiological significance of sunlight and fluorescent lighting in malignant melanoma: A case-control study. Br J Cancer. 1985;52:765-9.
73. 72. Elwood JM, Williamson C, Stapleton PJ. Malignant melanoma in relation to moles, pigmentation, and exposure to fluorescent and other lighting sources. Br J Cancer 1986; 53:65-74.
74. 73. Cristofolini M, Franceschi S, Tasin L, et al. Risk factors for cutaneous malignant melanoma in a northern Italian population. Int J Cancer 1987;39:150-4.
75. 74. Osterlind A, Hou-Jensen K, Moller-Jensen O. Incidence of cutaneous malignant melanoma in Denmark 1978-1982. Anatomic site distribution, histologic types, and comparison with non-melanoma skin cancer. Br J Cancer 1988;58: 385-91.
76. 75. Weinstock MA, Colditz GA, Willett W, et al. Nonfamilial cutaneous melanoma incidence in women associated with sun exposure before 20 years of age. Pediatrics 1989;84: 199-204.
77. 76. MacKie RM, Freudenberger T, Aitchison TC. Personal risk-factor chart for cutaneous melanoma. Lancet 1989;2: 487-90.
78. 77. Armstrong BK, English DR. Epidemiological studies. In: Balch CM, Houghton AN, Milton GW, et al, editors. Cutaneous melanoma. Philadelphia: JP Lippincott 1992;2:12-26.